These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8395334)

  • 21. Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma.
    O'Nualláin EM; Puri P; Mealy K; Reen DJ
    Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):96-101. PubMed ID: 7606873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages.
    Jovanovic DV; Di Battista JA; Martel-Pelletier J; Jolicoeur FC; He Y; Zhang M; Mineau F; Pelletier JP
    J Immunol; 1998 Apr; 160(7):3513-21. PubMed ID: 9531313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-10 and IL-4 synergize with TNF-alpha to induce IL-1ra production by human neutrophils.
    Marie C; Pitton C; Fitting C; Cavaillon JM
    Cytokine; 1996 Feb; 8(2):147-51. PubMed ID: 8777273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals.
    Netea MG; Hancu N; Blok WL; Grigorescu-Sido P; Popa L; Popa V; van der Meer JW
    Cytokine; 1997 Apr; 9(4):284-7. PubMed ID: 9112337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact.
    Jungo F; Dayer JM; Modoux C; Hyka N; Burger D
    Cytokine; 2001 Jun; 14(5):272-82. PubMed ID: 11444907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular IL-1 receptor antagonist is elevated in human dermal fibroblasts that overexpress intracellular precursor IL-1 alpha.
    Higgins GC; Wu Y; Postlethwaite AE
    J Immunol; 1999 Oct; 163(7):3969-75. PubMed ID: 10490999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellulose acetate beads induce release of interleukin-1 receptor antagonist, but not tumour necrosis factor-alpha or interleukin-1beta in human peripheral blood.
    Takeda Y; Hiraishi K; Takeda H; Shiobara N; Shibusawa H; Saniabadi AR; Adachi M; Kawata S
    Inflamm Res; 2003 Jun; 52(7):287-90. PubMed ID: 12861393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence of neutrophils induces release of soluble tumor necrosis factor receptor forms.
    Lantz M; Björnberg F; Olsson I; Richter J
    J Immunol; 1994 Feb; 152(3):1362-9. PubMed ID: 7905502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancer.
    Kopp WC; Urba WJ; Rager HC; Alvord WG; Oppenheim JJ; Smith JW; Longo DL
    Clin Cancer Res; 1996 Mar; 2(3):501-6. PubMed ID: 9816196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-1beta influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis.
    Kopp S; Alstergren P; Ernestam S; Nordahl S; Bratt J
    Scand J Rheumatol; 2006; 35(3):182-8. PubMed ID: 16766364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
    Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW
    J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis.
    Bendele AM; Chlipala ES; Scherrer J; Frazier J; Sennello G; Rich WJ; Edwards CK
    Arthritis Rheum; 2000 Dec; 43(12):2648-59. PubMed ID: 11145022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
    Muzaffer MA; Dayer JM; Feldman BM; Pruzanski W; Roux-Lombard P; Schneider R; Laxer RM; Silverman ED
    J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients.
    Moutabarrik A; Nakanishi I; Namiki M; Tsubakihara Y
    Clin Nephrol; 1995 Apr; 43(4):243-8. PubMed ID: 7606878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease.
    Tilg H; Vogel W; Wiedermann CJ; Shapiro L; Herold M; Judmaier G; Dinarello CA
    Hepatology; 1993 Nov; 18(5):1132-8. PubMed ID: 8225219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis: rapid induction of tumor necrosis factor alpha, interleukin 1 beta, interleukin 6, gamma-interferon, and soluble interleukin 2 receptor (Mr 55,000 protein).
    List J; Moser RP; Steuer M; Loudon WG; Blacklock JB; Grimm EA
    Cancer Res; 1992 Mar; 52(5):1123-8. PubMed ID: 1737371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine-induced interleukin-1 receptor antagonist release in mononuclear phagocytes.
    Marsh CB; Wewers MD
    Am J Respir Cell Mol Biol; 1994 May; 10(5):521-5. PubMed ID: 8179914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The biological role of naturally-occurring cytokine inhibitors.
    Arend WP; Malyak M; Bigler CF; Smith MF; Janson RW
    Br J Rheumatol; 1991; 30 Suppl 2():49-52. PubMed ID: 1847086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.